Featured by Newsweek & World Class Media Outlets

Interviews

Industry

Jorge Santos da Silva
Jorge Santos da Silva
Founder & CEO
MoonLake Immunotherapeutics
2025-03-28

​MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company based in Zug, Switzerland, specializing in developing next-generation therapies for inflammatory diseases, notably through its investigational Nanobody therapy, sonelokimab.

READ MORE
Catherine Pickering
Catherine Pickering
CEO & Co-Founder
iOnctura
2025-03-28

iOnctura is a clinical-stage biotechnology company developing precision small molecule therapies that target tumour-intrinsic and immune-mediated resistance mechanisms in hard-to-treat cancers.

READ MORE
Fredrika Klarén
Fredrika Klarén
Head of Sustainability
Polestar
2025-03-28

Consumers today need hope—they need to see that choosing a more sustainable option does not mean compromising on design, performance, or convenience.

READ MORE
Antony Mattessich
Antony Mattessich
CEO
Amphista Therapeutics
2025-03-27

Amphista Therapeutics is a biotechnology company specializing in targeted protein degradation to develop novel treatments for diseases, with a focus on oncology.

READ MORE
Alberto Benegas Lynch Jr.
Alberto Benegas Lynch Jr.
Economist
Argentina
2025-03-27

Argentina has long suffered from economic stagnation due to interventionist policies. The current administration represents a break from that tradition, aiming to dismantle structures that have hindered economic freedom. However, political challenges and institutional resistance remain significant obstacles. For liberalism to endure, it must not only implement economic reforms but also foster a cultural shift towards valuing individual responsibility and market-driven solutions.

READ MORE
Gordon C. McCauley
Gordon C. McCauley
President & CEO
adMare BioInnovations
2025-03-26

adMare BioInnovations is a Canadian life sciences organization focused on advancing biotech innovation by providing resources, expertise, infrastructure, and support to emerging companies in the sector.

READ MORE
Pat Smallcombe
Pat Smallcombe
CEO
Metagenics
2025-03-26

Metagenics has a unique story. Founded in 1983, it was one of the pioneers of functional medicine in the United States. It is built on credible science and exceptional product quality - vital for delivering great healthcare.

READ MORE
Michael Mahaz
Michael Mahaz
SVP Global Business Units, Healthcare
Jabil
2025-03-26

Jabil is a global engineering, supply chain, and manufacturing solutions provider. Its healthcare division specializes in the design, development, and production of medical devices, orthopedic, diagnostics, pharmaceutical development and delivery systems, and digital health technologies for healthcare and life sciences companies.

READ MORE
Tim Herbert
Tim Herbert
Chairman & CEO
Inspire Medical Systems
2025-03-25

Inspire Medical Systems, Inc., is a medical technology company dedicated to redefining the standard of care for obstructive sleep apnea (OSA). 

READ MORE
Marc Dunoyer
Marc Dunoyer
CEO
Alexion 
2025-03-21

Our priority is to allocate resources effectively. If a drug does not show a strong enough potential benefit, we prefer to discontinue it early rather than invest in late-stage trials with a high risk of failure. Our goal is not just to bring a new drug to market, but to ensure it provides a meaningful benefit and improvement over existing options, if any exist. Strategic portfolio management is essential in rare disease research, where development costs are high and patient populations are small.

READ MORE